Cargando…

Multiple sclerosis: major histocompatibility complexity and antigen presentation

Multiple sclerosis (MS), like many putative autoimmune diseases, has been known to be associated with the human leukocyte antigen (HLA) class II region for more than 3 decades. However, exactly how HLA class II alleles increase the risk of MS is not yet conclusively known. Recent work in large human...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramagopalan, Sreeram V, Ebers, George C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808740/
https://www.ncbi.nlm.nih.gov/pubmed/19895714
http://dx.doi.org/10.1186/gm105
_version_ 1782176532691681280
author Ramagopalan, Sreeram V
Ebers, George C
author_facet Ramagopalan, Sreeram V
Ebers, George C
author_sort Ramagopalan, Sreeram V
collection PubMed
description Multiple sclerosis (MS), like many putative autoimmune diseases, has been known to be associated with the human leukocyte antigen (HLA) class II region for more than 3 decades. However, exactly how HLA class II alleles increase the risk of MS is not yet conclusively known. Recent work in large human cohorts has highlighted the fact that nearly all common HLA-DRB1 allelotypes are either positively or negatively associated with the disease, detracting from allele-specific antigen presentation as the sole mechanism of MHC associated disease susceptibility. Here, we put into context recent data on the HLA class II region in MS, including allelic heterogeneity, gene-environment interactions and epigenetics. It is clear that a complete understanding of the epistatic interactions and epigenetic features of this region will be crucial to comprehending disease pathogenesis.
format Text
id pubmed-2808740
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28087402010-11-06 Multiple sclerosis: major histocompatibility complexity and antigen presentation Ramagopalan, Sreeram V Ebers, George C Genome Med Commentary Multiple sclerosis (MS), like many putative autoimmune diseases, has been known to be associated with the human leukocyte antigen (HLA) class II region for more than 3 decades. However, exactly how HLA class II alleles increase the risk of MS is not yet conclusively known. Recent work in large human cohorts has highlighted the fact that nearly all common HLA-DRB1 allelotypes are either positively or negatively associated with the disease, detracting from allele-specific antigen presentation as the sole mechanism of MHC associated disease susceptibility. Here, we put into context recent data on the HLA class II region in MS, including allelic heterogeneity, gene-environment interactions and epigenetics. It is clear that a complete understanding of the epistatic interactions and epigenetic features of this region will be crucial to comprehending disease pathogenesis. BioMed Central 2009-11-06 /pmc/articles/PMC2808740/ /pubmed/19895714 http://dx.doi.org/10.1186/gm105 Text en Copyright ©2009 BioMed Central Ltd
spellingShingle Commentary
Ramagopalan, Sreeram V
Ebers, George C
Multiple sclerosis: major histocompatibility complexity and antigen presentation
title Multiple sclerosis: major histocompatibility complexity and antigen presentation
title_full Multiple sclerosis: major histocompatibility complexity and antigen presentation
title_fullStr Multiple sclerosis: major histocompatibility complexity and antigen presentation
title_full_unstemmed Multiple sclerosis: major histocompatibility complexity and antigen presentation
title_short Multiple sclerosis: major histocompatibility complexity and antigen presentation
title_sort multiple sclerosis: major histocompatibility complexity and antigen presentation
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808740/
https://www.ncbi.nlm.nih.gov/pubmed/19895714
http://dx.doi.org/10.1186/gm105
work_keys_str_mv AT ramagopalansreeramv multiplesclerosismajorhistocompatibilitycomplexityandantigenpresentation
AT ebersgeorgec multiplesclerosismajorhistocompatibilitycomplexityandantigenpresentation